MedPath

FUNDACIO PRIVADA MON CLINIC BARCELONA

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:1
Completed:0

Trial Phases

3 Phases

Phase 1:1
Phase 4:1
Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (66.7%)
Phase 1
1 (16.7%)
Phase 4
1 (16.7%)

The RECOVERY Study: Using Supersaturated Oxygen Therapy To Treat Small Vessel Blockages After a Heart Attack

Not Applicable
Active, not recruiting
Conditions
Anterior STEMI
First Posted Date
2025-06-02
Last Posted Date
2025-06-02
Lead Sponsor
Fundacio Privada Mon Clinic Barcelona
Target Recruit Count
20
Registration Number
NCT07000266
Locations
🇪🇸

Hospital Clínic de Barcelona, Barcelona, Spain

EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG

Not Applicable
Not yet recruiting
Conditions
Portal Hypertension
Chronic Liver Disease (CLD)
Cirrhosis
First Posted Date
2025-03-07
Last Posted Date
2025-03-07
Lead Sponsor
Fundacio Privada Mon Clinic Barcelona
Target Recruit Count
20
Registration Number
NCT06863012

Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study

Recruiting
Conditions
Respiratory Synctial Virus
COPD
Chronic Obstructive Pulmonary Disease (COPD)
Exacerbation of COPD
First Posted Date
2024-12-16
Last Posted Date
2025-02-26
Lead Sponsor
Fundacio Privada Mon Clinic Barcelona
Target Recruit Count
892
Registration Number
NCT06735612
Locations
🇪🇸

Hospital Clínic de Barcelona, Barcelona, Spain

Changes in Eye Pressure in Glaucoma Patients Treated with Istent Inject W, Monitored by a Contact Lens Sensor

Not Applicable
Recruiting
Conditions
Glaucoma Eye
First Posted Date
2024-09-23
Last Posted Date
2025-03-06
Lead Sponsor
Fundacio Privada Mon Clinic Barcelona
Target Recruit Count
53
Registration Number
NCT06607705
Locations
🇪🇸

Institut Català de Retina, Barcelona, Spain

🇪🇸

Hospital Clínic de Barcelona, Barcelona, Spain

ANTES B+ Clinical Trial

Phase 4
Recruiting
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: Trelegy Ellipta 100/62.5/25Mcg Inh 30D
Drug: Brimica
Drug: Ulunar
Drug: Xoterna
Drug: Laventair
Drug: Yanimo
Drug: Broncoral
Drug: Oxis
Drug: Formatris
Drug: Striverdi
Drug: Beglan
Drug: Betamican
Drug: Inaspir
Drug: Soltel
Drug: Bretaris
Drug: Seebri
Drug: Tovanor
Drug: Enurev
Drug: Tavulus
Drug: Sirkava
Drug: Braltus
Drug: Gregal
Drug: Rolufta
First Posted Date
2024-02-28
Last Posted Date
2024-03-05
Lead Sponsor
Fundacio Privada Mon Clinic Barcelona
Target Recruit Count
1028
Registration Number
NCT06282861
Locations
🇪🇸

Hospital Clínic Barcelona, Barcelona, Catalunya, Spain

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.